Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)"

Affiliations

¹ Medical Oncology-Department of Translational Medicine (DIMET), Università del Piemonte Orientale (UPO), "Maggiore della Carità" University Hospital, Novara, Italy.
² Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genoa, Italy.
³ Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy.
⁴ Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy.
⁵ Medical Oncology Department, I+12 Biomedical Research Institute, Hospital Universitario 12 de Octubre, Madrid, Spain.

Comment

Carlo Cattrini et al. Int J Cancer. 2022.

. 2022 Dec 15;151(12):2291-2292.

doi: 10.1002/ijc.34246. Epub 2022 Sep 5.

¹ Medical Oncology-Department of Translational Medicine (DIMET), Università del Piemonte Orientale (UPO), "Maggiore della Carità" University Hospital, Novara, Italy.
² Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genoa, Italy.
³ Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy.
⁴ Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy.
⁵ Medical Oncology Department, I+12 Biomedical Research Institute, Hospital Universitario 12 de Octubre, Madrid, Spain.

No abstract available

Comment on

Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
James ND, Clarke NW, Cook A, Ali A, Hoyle AP, Attard G, Brawley CD, Chowdhury S, Cross WR, Dearnaley DP, de Bono JS, Diaz-Montana C, Gilbert D, Gillessen S, Gilson C, Jones RJ, Langley RE, Malik ZI, Matheson DJ, Millman R, Parker CC, Pugh C, Rush H, Russell JM, Berthold DR, Buckner ML, Mason MD, Ritchie AWS, Birtle AJ, Brock SJ, Das P, Ford D, Gale J, Grant W, Gray EK, Hoskin P, Khan MM, Manetta C, McPhail NJ, O'Sullivan JM, Parikh O, Perna C, Pezaro CJ, Protheroe AS, Robinson AJ, Rudman SM, Sheehan DJ, Srihari NN, Syndikus I, Tanguay JS, Thomas CW, Vengalil S, Wagstaff J, Wylie JP, Parmar MKB, Sydes MR; STAMPEDE Trials Collaborative Group. James ND, et al. Int J Cancer. 2022 Aug 1;151(3):422-434. doi: 10.1002/ijc.34018. Epub 2022 May 16. Int J Cancer. 2022. PMID: 35411939 Free PMC article. Clinical Trial.